|
Amyotrophic lateral sclerosis (ALS), is a rapidly progressive, invariably fatal neurological disease that attacks the nerve cells (neurons) responsible for controlling voluntary muscles. The disease belongs to a group of disorders known as motor neuron diseases, which are characterized by the gradual degeneration and death of motor neurons.
|
[News]
History of Cerebral Palsy in Children
Cerebral palsy is not a new disorder. There have probably been children with cerebral palsy as long as there have been children. But the medical profession did not begin to study cerebral palsy as a distinct medical condition until 1861.
|
|
[News]
Cerebral Palsy Statistics
Because cerebral palsy influences the way children develop, it is known as a developmental disability. In the United States today, more people have cerebral palsy than any other developmental disability, including Down syndrome, epilepsy, and autism.
|
|
[News]
Cerebral Palsy Diagnosis
How is the diagnosis of cerebral palsy made? When an infant or child has brain damage, a variety of symptoms can lead doctors and parents to suspect that something is wrong. In the first few months of life, an infant with brain damage may demonstrate some or all of the following symptoms that can indicate.
|
|
[News]
Therapy and Treatment for Cerebral Palsy
Following your child's interdisciplinary assessment, the professionals providing care for your child will develop recommendations for treatment of his or her cerebral palsy. Many treatments are available to help a child function at the highest level possible. Although many treatments are available, we will touch upon a few of the most basic approaches used today to help a children with cerebral palsy achieve their optimal level of functioning.
|
|
[News]
The Cerebral Palsy and the treatment
The term cerebral palsy refers to any one of a number of neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination but don't worsen over time.
|
|
[News]
New Embryonic Stem Cell Trials Approved to Treat Rare Form of Blindness
In what could be a significant step forward for human embryonic stem cell science Massachusetts based Advanced Cell Technology (ACT) has announced that the FDA have granted orphan drug status to MA09-hRPE ¨C a human embryonic stem cell (hESC) derived treatment for a rare type of blindness known as Stargardt's Macular Dystrophy.
|
|
[Q&A]
Does your medical center also offer conventional treatment?
Our treatment program is a combination of conventional medicine and stem cell therapy, but we do offer conventional treatment, especially for the patients with certain neurological conditions caused by non-neural degeneration or non-inherited diseases such as post-stroke, brain trauma, etc.
There could be a significant difference between the conventional treatments. For example, to treat a post-stoke patient, the principal therapeutic goal of conventional medicine is to prevent a recurring stoke, by removing the risk factors, while our stem cell therapy would allow the restoration of some of the lost brain functioning by re-establishing the neural connections.
In our center, it's basically the patient's decision whether they want to have only the conventional medicine or a program that combines both conventional and stem cell therapy. We have also successfully treated over 100 post-stroke and brain trauma patients with conventional medicine only.
|
|
[Q&A]
If your hospitals have an age restriction on patients?
Previously, the minimum age for stem cell treatment was 3 years old. This age was imposed by Dr. Wu's medical team because the stem cell treatment technology was not as advanced at that time. Now the treatment technology is far better and completely safe and our medical center has now treated patients as young as 4 months old. The safety while treating such young patients can be guaranteed because of the increased effectiveness and development of the stem cell treatment technology over the past several years.
|
|
|
|
|
[
[
[
[
[
[
[
[
[
[